420 related articles for article (PubMed ID: 25660362)
1. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination.
El-Akabawy G; Rashed LA
Ann Anat; 2015 Mar; 198():11-20. PubMed ID: 25660362
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Salinas Tejedor L; Berner G; Jacobsen K; Gudi V; Jungwirth N; Hansmann F; Gingele S; Prajeeth CK; Baumgärtner W; Hoffmann A; Skripuletz T; Stangel M
Brain Behav Immun; 2015 Nov; 50():155-165. PubMed ID: 26140734
[TBL] [Abstract][Full Text] [Related]
3. 17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Ragerdi Kashani I; Hedayatpour A; Pasbakhsh P; Kafami L; Atlasi N; Pirhajati Mahabadi V; Mamoudi R; Baazm M
Acta Med Iran; 2012; 50(12):789-97. PubMed ID: 23456519
[TBL] [Abstract][Full Text] [Related]
4. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
[TBL] [Abstract][Full Text] [Related]
6. Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.
Glenn JD; Smith MD; Kirby LA; Baxi EG; Whartenby KA
PLoS One; 2015; 10(9):e0139008. PubMed ID: 26407166
[TBL] [Abstract][Full Text] [Related]
7. Effect of Multiple Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cells on Cuprizone Model of Multiple Sclerosis.
Marzban M; Mousavizadeh K; Bakhshayesh M; Vousooghi N; Vakilzadeh G; Torkaman-Boutorabi A
Iran Biomed J; 2018 Sep; 22(5):312-21. PubMed ID: 29409311
[TBL] [Abstract][Full Text] [Related]
8. The comparative effects of bone marrow mesenchymal stem cells and supernatant transplantation on demyelination and inflammation in cuprizone model.
Tahmasebi F; Asl ER; Vahidinia Z; Faghihi F; Barati S
Mol Biol Rep; 2024 May; 51(1):674. PubMed ID: 38787497
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
Kassis I; Petrou P; Halimi M; Karussis D
Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bone Marrow Mesenchymal Stem Cells on Myelin Repair and Emotional Changes of a Cuprizone-Induced Demyelination Model.
Lei C; Chen H; Chen K
J Integr Neurosci; 2023 Feb; 22(2):40. PubMed ID: 36992584
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases.
Karussis D; Kassis I; Kurkalli BG; Slavin S
J Neurol Sci; 2008 Feb; 265(1-2):131-5. PubMed ID: 17610906
[TBL] [Abstract][Full Text] [Related]
13. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
[TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of SDF-1α-preconditioned bone marrow mesenchymal cells improves remyelination in the cuprizone-induced mouse model of multiple sclerosis.
Beigi Boroujeni F; Pasbakhsh P; Mortezaee K; Pirhajati V; Alizadeh R; Aryanpour R; Madadi S; Ragerdi Kashani I
Cell Biol Int; 2020 Feb; 44(2):499-511. PubMed ID: 31631484
[TBL] [Abstract][Full Text] [Related]
15. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
[TBL] [Abstract][Full Text] [Related]
16. The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
Kråkenes T; Wergeland S; Al-Sharabi N; Mohamed-Ahmed S; Fromreide S; Costea DE; Mustafa K; Bø L; Kvistad CE
PLoS One; 2023; 18(11):e0293908. PubMed ID: 37943848
[TBL] [Abstract][Full Text] [Related]
17. The effects of mesenchymal stem cells transplantation on A1 neurotoxic reactive astrocyte and demyelination in the cuprizone model.
Barati S; Kashani IR; Tahmasebi F
J Mol Histol; 2022 Apr; 53(2):333-346. PubMed ID: 35031895
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.
Gharibi T; Ahmadi M; Seyfizadeh N; Jadidi-Niaragh F; Yousefi M
Cell Immunol; 2015 Feb; 293(2):113-21. PubMed ID: 25596473
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC
Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis.
Harris VK; Yan QJ; Vyshkina T; Sahabi S; Liu X; Sadiq SA
J Neurol Sci; 2012 Feb; 313(1-2):167-77. PubMed ID: 21962795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
